HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ingemar F Petersson Selected Research

Rheumatoid Arthritis

1/2017Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors.
1/2017A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
12/2016Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.
2/2016Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
11/2015Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.
6/2015Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
6/2015Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
5/2015The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
12/2013Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
8/2013Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ingemar F Petersson Research Topics

Disease

21Rheumatoid Arthritis
01/2017 - 01/2005
9Arthritis (Polyarthritis)
12/2015 - 06/2009
6Pain (Aches)
02/2016 - 01/2005
5Necrosis
05/2015 - 05/2007
4Fatigue
02/2016 - 03/2014
4Psoriatic Arthritis
02/2016 - 10/2010
3Ankylosing Spondylitis
02/2016 - 02/2012
2Knee Osteoarthritis
04/2017 - 12/2006
2Chronic Pain
11/2014 - 01/2005
2Osteoarthritis
09/2007 - 12/2006
2Rheumatic Diseases (Rheumatism)
01/2005 - 01/2005
1Psoriasis (Pustulosis Palmaris et Plantaris)
06/2016
1Axial Spondyloarthritis
02/2016
1Back Pain (Backache)
02/2016
1Non-Radiographic Axial Spondyloarthritis
12/2015
1Infections
05/2015
1Pneumococcal Infections
05/2015
1Spondylarthropathies
05/2015
1Spondylarthritis (Spinal Arthritis)
10/2010
1Genetic Predisposition to Disease (Genetic Predisposition)
12/2006
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2006
1Vasculitis (Vasculitides)
09/2006
1Cardiovascular Diseases (Cardiovascular Disease)
07/2005
1Rheumatoid Vasculitis
01/2005
1Felty Syndrome (Syndrome, Felty's)
01/2005

Drug/Important Bio-Agent (IBA)

7Methotrexate (Mexate)FDA LinkGeneric
01/2017 - 03/2011
6Tumor Necrosis Factor InhibitorsIBA
01/2017 - 07/2005
5Biomarkers (Surrogate Marker)IBA
01/2017 - 12/2006
5Infliximab (Remicade)FDA Link
12/2016 - 02/2012
5Biological ProductsIBA
06/2016 - 06/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 07/2005
2C-Reactive ProteinIBA
12/2015 - 11/2015
2ametantrone (HAQ)IBA
03/2015 - 03/2014
2Adalimumab (Humira)FDA Link
10/2013 - 02/2012
2Etanercept (Enbrel)FDA Link
10/2013 - 02/2012
2Complement System Proteins (Complement)IBA
03/2013 - 01/2005
2Antirheumatic Agents (DMARD)IBA
05/2012 - 03/2011
2Pharmaceutical PreparationsIBA
06/2009 - 01/2005
2HLA-DRB1 Chains (HLA DRB1)IBA
09/2006 - 01/2005
13-benzoyl dopamine (MBDA)IBA
01/2017
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
02/2016
1AutoantigensIBA
02/2016
1Peptides (Polypeptides)IBA
02/2016
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2015
1Conjugate VaccinesIBA
05/2015
1Prednisolone (Predate)FDA LinkGeneric
05/2015
1Analgesics (Analgesic Drugs)IBA
05/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2015
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
11/2014
1RA 25IBA
01/2014
1Sulfasalazine (Azulfidine)FDA LinkGeneric
12/2013
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2013
1factor AIBA
10/2013
1Proteins (Proteins, Gene)FDA Link
12/2006
1Cartilage Oligomeric Matrix ProteinIBA
12/2006
1Messenger RNA (mRNA)IBA
12/2006
13' Untranslated Regions (3' UTR)IBA
12/2006
1HLA-C Antigens (HLA-C)IBA
09/2006
1HLA-DQB1 antigen (HLA DQB1)IBA
01/2005
1HLA-DRB1*04:01 antigenIBA
01/2005
1HLA-DRB1*04 antigenIBA
01/2005
1EpitopesIBA
01/2005

Therapy/Procedure

5Therapeutics
01/2017 - 02/2012
1Replacement Arthroplasty
04/2017
1Hip Replacement Arthroplasty (Total Hip Replacement)
04/2011
1Knee Replacement Arthroplasty (Total Knee Replacement)
12/2005
1Massage (Zone Therapy)
01/2005